Activ Surgical
Founded Year
2017Stage
Series B - IV | AliveTotal Raised
$102.4MLast Raised
$15M | 3 yrs agoMosaic Score The Mosaic Score is an algorithm that measures the overall financial health and market potential of private companies.
-109 points in the past 30 days
About Activ Surgical
Activ Surgical specializes in intraoperative surgical intelligence within the medical technology sector. The company's primary offering, ActivSight Intelligent Light, provides surgeons with real-time visual insights and information that reveal critical physiological structures and functions during surgery. Activ Surgical's products are designed to enhance surgical precision and patient care by integrating augmented reality, artificial intelligence, and machine learning technologies. Activ Surgical was formerly known as Omniboros, Inc. It was founded in 2017 and is based in Boston, Massachusetts.
Loading...
ESPs containing Activ Surgical
The ESP matrix leverages data and analyst insight to identify and rank leading companies in a given technology landscape.
The augmented reality/virtual reality (AR/VR) surgical guidance & navigation market (also called spatial computing surgical guidance & navigation) is a rapidly advancing field that aims to revolutionize surgical procedures by leveraging immersive technologies. This market offers solutions that utilize AR and VR technologies to provide surgeons with real-time, interactive, and three-dimensional vis…
Activ Surgical named as Highflier among 12 other companies, including Proprio, MediView, and Pixee Medical.
Activ Surgical's Products & Differentiators
ActivInsights™ software suite
The ActivInsights software suite is a proprietary augmented reality (AR)-based bundle that offers real-time tissue assessment for surgeons through previously unavailable visual overlays. The software suite is designed to transform massive amounts of data gathered intra-operatively to provide surgeons real-time guidance in the operating room. The first offering from the ActivInsights software suite that will be available to surgeons is the Perfusion View Insight, will be underpinned by the industry's largest annotated data set and will provide the ability to visualize blood flow and perfusion for procedures such as anastomosis and colorectal cases in real time, without the use of traditional dyes.
Loading...
Research containing Activ Surgical
Get data-driven expert analysis from the CB Insights Intelligence Unit.
CB Insights Intelligence Analysts have mentioned Activ Surgical in 5 CB Insights research briefs, most recently on Jan 5, 2024.
May 17, 2022 report
AI 100: The most promising artificial intelligence startups of 2022
Feb 16, 2022
The 130+ AI startups reinventing healthcareExpert Collections containing Activ Surgical
Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.
Activ Surgical is included in 4 Expert Collections, including Digital Health.
Digital Health
11,257 items
The digital health collection includes vendors developing software, platforms, sensor & robotic hardware, health data infrastructure, and tech-enabled services in healthcare. The list excludes pureplay pharma/biopharma, sequencing instruments, gene editing, and assistive tech.
Digital Health 50
150 items
The winners of the third annual CB Insights Digital Health 150.
AI 100
100 items
Artificial Intelligence
7,222 items
Activ Surgical Patents
Activ Surgical has filed 26 patents.
The 3 most popular patent topics include:
- medical imaging
- surgical instruments
- medical equipment
Application Date | Grant Date | Title | Related Topics | Status |
|---|---|---|---|---|
5/24/2023 | 10/29/2024 | Machine learning, Surgery, Surgical removal procedures, Classification algorithms, Medical imaging | Grant |
Application Date | 5/24/2023 |
|---|---|
Grant Date | 10/29/2024 |
Title | |
Related Topics | Machine learning, Surgery, Surgical removal procedures, Classification algorithms, Medical imaging |
Status | Grant |
Latest Activ Surgical News
Jan 27, 2025
The company will use the funds to scale operations and accelerate its innovation and commercialization initiatives. Photo: andresr/Getty Images Elucent Medical, a guided surgical technology company, will receive $30 million in growth capital from Trinity Capital. WHAT IT DOES Elucent Medical's flagship product EnVisio System utilizes a spatial field generator measuring continuous data points across multiple planes to display exact 3D positioning of the SmartClip marker and SmartSensor that is used to guide soft-tissue surgical excision. Elucent will use the funds to scale operations and expand its innovation and commercialization initiatives. "Our EnVisio System gives surgeons confidence before, during and after their surgical procedures so they know they have delivered unparalleled accuracy and precision for their patients," Jason Pesterfield, CEO of Elucent, said in a statement. "We are in scale mode and are excited to partner with Trinity Capital. Trinity Capital's investment will be key to our continued acceleration of our innovation and commercialization efforts." MARKET SNAPSHOT Elucent president and CEO Jason Pesterfield, told MobiHealthNews that the company raised $44 million in a Series C funding round in early 2024. Other companies in this space include MediViewXR , a medtech company that utilizes augmented reality and develops extended reality surgical navigation used in ablation and biopsy of cancerous tumors. In 2024, GE HealthCare and MediViewXR announced the successful clinical use of their co-developed OmnifyXR Interventional Suite System . OmnifyXR pairs GE's imaging technology with MediView's AR and surgical navigation platform to help physicians better assess a patient's anatomy, make more informed clinical decisions and allow for remote collaboration by care teams in different locations. AI-enabled surgical technology company Proprio secured $43 million in Series B funding in 2023 from new and existing investors, including Bird B. The company offers a surgical navigation platform dubbed Paradigm, which utilizes light field technology and artificial intelligence to generate 3D visualization of surgery, allowing for intraoperative scans to be seen in real-time. It also offers a platform called Volumetric Intelligence that combines medical images with data from Paradigm's sensor. Boston-based Activ Surgical is a digital surgery company that focuses on improving surgical efficiency, accuracy, patient outcomes and accessibility for both endoscopic and robotically-assisted procedures. Activ Surgical’s surgical software platform is driven by computer vision, artificial intelligence, analytics and machine learning to enhance a surgeon’s intraoperative decision making and reduce unintended and preventable surgical complications. In 2021, Activ Surgical announced a $45 million Series B funding round. Tags:
Activ Surgical Frequently Asked Questions (FAQ)
When was Activ Surgical founded?
Activ Surgical was founded in 2017.
Where is Activ Surgical's headquarters?
Activ Surgical's headquarters is located at 30 Thomson Place, Boston.
What is Activ Surgical's latest funding round?
Activ Surgical's latest funding round is Series B - IV.
How much did Activ Surgical raise?
Activ Surgical raised a total of $102.4M.
Who are the investors of Activ Surgical?
Investors of Activ Surgical include Tao Capital Partners, LRVHealth, Magnetar Capital, Cota Capital, Rising Tide and 21 more.
Who are Activ Surgical's competitors?
Competitors of Activ Surgical include CMR Surgical, Asensus Surgical, Quantum Surgical, Theator, Vicarious Surgical and 7 more.
What products does Activ Surgical offer?
Activ Surgical's products include ActivInsights™ software suite and 1 more.
Loading...
Compare Activ Surgical to Competitors
Quantum Surgical focuses on interventional oncology. The company offers the Epione robotic platform, which is designed for the planning, targeting, delivery, and confirmation of tumor ablation treatments. The technology primarily serves the healthcare sector, with a focus on improving cancer treatment through minimally invasive procedures. It was founded in 2017 and is based in Montpellier, France.
CMR Surgical specializes in the development of robotic-assisted surgical devices within the medical devices industry. The company offers the Versius Surgical System, which is designed to assist surgeons in performing minimal access surgery. It primarily serves the healthcare sector, focusing on hospitals and medical professionals. CMR Surgical was formerly known as Cambridge Medical Robotics. It was founded in 2014 and is based in Cambridge, United Kingdom.
Asensus Surgical focuses on the development and manufacturing of digital laparoscopy and surgical robotics. The company's main offerings include the surgical system and the intelligent surgical unit. It primarily serves the healthcare industry, particularly the surgical technology sector. Asensus Surgical was formerly known as TransEnterix. It was founded in 2006 and is based in Durham, North Carolina. In August 2024, Asensus Surgical was acquired by Karl Storz.
Proximie is a technology company that provides a cloud-based software platform in the healthcare sector. The company offers solutions for connectivity, data management, and analytics aimed at surgical procedures and medtech. Proximie's products are intended for medtech companies and hospital systems. It was founded in 2016 and is based in London, England.
Caresyntax focuses on surgical outcomes through its AI-powered, vendor-neutral surgical data platform. The company offers a suite of services that include operational analytics, clinical outcome improvement, and financial optimization for healthcare providers. Caresyntax primarily serves hospitals, surgery centers, surgeons, perioperative leaders, insurers, risk managers, and medtech partners. It was founded in 2013 and is based in Larkspur, California.
Bionaut Labs specializes in precision microtechnology within the healthcare sector. The company develops microscale robots designed to deliver biologics or small molecule therapies locally to targeted disease areas, particularly for patients with severe brain disorders. The company's micro-robots are navigated through the body using external magnetic propulsion for precise treatment and diagnostic purposes. It was founded in 2016 and is based in Los Angeles, California.
Loading...